Gregory Otterson, MDThe James Cancer Center
- Lung Cancers
- Medical Oncology
- Pleural Cancers
- Thymus Cancers
Make an Appointment
I’m a thoracic oncologist dedicated to advancing the care and treatment of patients with thoracic malignancies – such as adenocarcinoma, mesothelioma and thymic cancers – by helping develop novel therapeutic approaches to these diseases. Such treatments range from combinations of conventional cytotoxic chemotherapy, novel targeted agents and immunotherapy applied to patients with early stage or advanced disease. I was named to the Castle Connolly list of “Regional Top Doctors” from 2006-2018 and rated in the top 10 percent of physicians in the nation for patient satisfaction in 2017.
I am a professor of internal medicine, associate division director for education in the Division of Medical Oncology, associate program director of the Hematology/Oncology Fellowship Program and clinical director of the Thoracic Oncology Disease Specific Research Group at OSUCCC – James. I serve on the National Comprehensive Cancer Network (NCCN) nonsmall cell lung cancer guidelines panel.
At The James, we have a true multi-disciplinary team in thoracic oncology that includes medical oncologists, thoracic surgeons, radiation oncologists, pulmonologists, pathologists, radiologists, nurses, pharmacists, nurse practitioners and physician assistants. Together we work to continually improve patients’ quality of life and develop effective therapies in an effort to end cancer.
Education and Background
Georgetown University School of Medicine
National Cancer Institute
- American Board of Internal Medicine
- American Board of Internal Medicine (Subspecialty: Medicine Oncology)
- Department of Internal Medicine
- Division of Medical Oncology
I see patients at
The James at Brain and Spine Hospital
300 West 10th Avenue, Columbus, Ohio 43210
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 3/26/2018, Dr. Otterson has reported no relationships with companies or entities.